Genzyme Corporation to Acquire ILEX Oncology, Inc. (27 Feb 2004) Takes Important Step to Establish Oncology Franchise at $26.00 per share, or approximately $1 billion in equityvalue. Excluding... this transaction brings significant value to ILEX shareholders and recognizes...